Is PG a good stock to buy now? We came across a bullish thesis on The Procter & Gamble Company on Phaetrix Investing’s Substack by Phaetrix. In this article, we will summarize the bulls’ thesis on PG. The Procter & Gamble Company’s share was trading at $155.22 as of March 9th. PG’s trailing and forward P/E were 22.76 and 20.92 respectively according to Yahoo Finance.
Copyright: serezniy / 123RF Stock Photo
Procter & Gamble Co. (PG) is one of the world’s largest consumer goods companies, selling branded products across beauty, grooming, health care, fabric and home care, and baby and family categories. The company generates roughly $85 billion in annual revenue and maintains strong profitability with gross margins near 51% and operating margins around 24%. Its portfolio of globally recognized brands and everyday essential products provides resilient demand and dependable cash generation.
Procter & Gamble produces about $15 billion in annual free cash flow, representing an 18% margin, and consistently returns capital to shareholders through approximately $10 billion in annual dividends and roughly $5 billion in share repurchases. With free cash flow per share around $6.40 and modest share count reductions each year, the company has built a reputation as a reliable dividend compounder supported by disciplined capital allocation.
Despite slower organic growth of roughly 2–3%, largely driven by pricing rather than volume expansion, Procter & Gamble continues to demonstrate pricing power and operational discipline through productivity initiatives and cost controls. Management is targeting additional efficiency gains, including a restructuring program expected to generate roughly $1.5 billion in savings, which could further support margins and earnings stability.
While tariffs and input cost inflation may create temporary pressure, the company’s scale, brand strength, and retail relationships position it well to manage these headwinds while protecting profitability. With net debt near $25 billion and strong interest coverage, the balance sheet remains solid and capable of supporting continued shareholder returns.
At around 21× earnings and roughly a 4% free cash flow yield, Procter & Gamble reflects a premium valuation relative to slower growth peers, but this premium is supported by the company’s stability, global brand leadership, and decades-long dividend track record.
For long-term investors seeking reliable income and steady compounding, the stock offers a durable investment profile. Procter & Gamble appears most attractive as a buy in the $120–$130 range, where the valuation provides a stronger margin of safety and enhances the long-term return potential while maintaining exposure to one of the most dependable consumer franchises in the market.
Previously, we covered a bullish thesis on Colgate-Palmolive Company (CL) by Kontra in October 2024, which highlighted the company’s global oral care leadership, strong presence in emerging markets, premiumization strategy, and high ROIC supporting its position as a quality compounder. CL’s stock price has depreciated by approximately 7.42% since our coverage. Phaetrix shares a similar view but emphasizes Procter & Gamble’s diversified consumer brands and strong free cash flow generation.
The Procter & Gamble Company is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 90 hedge fund portfolios held PG at the end of the fourth quarter which was 87 in the previous quarter. While we acknowledge the risk and potential of PG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PG and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy NOW
Disclosure: None.
